Trial
NCT06833281
Extension Study of Participants From SPG302-ALZ-101
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Spinogenix
Collaborators
—
Condition
Alzheimer's Disease
Intervention
SPG302
Why stopped
patients treated on compassionate use program
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-18